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It is unknown whether measures adapted from social neu-
roscience linked to specific neural systems will demon-
strate relationships to external variables. Four paradigms 
adapted from social neuroscience were administered to 173 
clinically stable outpatients with schizophrenia to deter-
mine their relationships to functionally meaningful vari-
ables and to investigate their incremental validity beyond 
standard measures of social and nonsocial cognition. The 
4 paradigms included 2 that assess perception of nonver-
bal social and action cues (basic biological motion and 
emotion in biological motion) and 2 that involve higher 
level inferences about self and others’ mental states (self- 
referential memory and empathic accuracy). Overall, social 
neuroscience paradigms showed significant relationships to 
functional capacity but weak relationships to community 
functioning; the paradigms also showed weak correlations 
to clinical symptoms. Evidence for incremental validity 
beyond standard measures of social and nonsocial cogni-
tion was mixed with additional predictive power shown for 
functional capacity but not community functioning. Of the 
newly adapted paradigms, the empathic accuracy task had 
the broadest external validity. These results underscore the 
difficulty of translating developments from neuroscience 
into clinically useful tasks with functional significance.
Key words: schizophrenia/social cognition/social 
neuroscience/functional outcome
Introduction
Social cognitive processes are centrally linked to voca-
tional achievement and daily and interpersonal func-
tioning in schizophrenia.1–3 Moreover, social cognition 
has been shown to mediate the relationship between 
nonsocial cognition and functionally meaningful out-
comes.4–7 Treatment research for social cognition in 
schizophrenia stands to benefit from measures adapted 
from social neuroscience, which may guide the develop-
ment of  targeted interventions by virtue of  being linked 
to specific cognitive subprocesses and neural substrates. 
In line with the Cognitive Neuroscience Treatment 
Research to Improve Cognition in Schizophrenia 
(CNTRICS) initiative,8 the Social Cognition and 
Functioning (SCAF) project selected social cognition 
tasks with good construct validity linked to specific 
neuroanatomical systems. SCAF goals and selection of 
neuroscience measures (which we refer to in this article 
as adapted social neuroscience measures) are described 
in a companion article.9 SCAF paradigms were selected 
by virtue of  their linkages to neural regions involving 
bottom-up (lower level) recognition of  social/emotional 
stimuli and top-down (higher level) mental state infer-
ences, 2 critical components of  the social-emotional pro-
cessing stream.10 Because social cognitive interventions 
are intended to eventually improve complex functional 
outcomes, it is important to evaluate the external valid-
ity of  newly adapted measures to gauge their utility for 
clinical trials.
It is an open question whether tasks that tap into nar-
rowly circumscribed social cognitive processes purchase 
increased sensitivity and specificity at the cost of attenu-
ated relationships with functioning. This is a valid con-
cern given that specialized cognitive paradigms evaluated 
as part of the CNTRICS initiative correlated relatively 
weakly with functional measures compared with clini-
cal neuropsychological tasks, possibly because specific 
subprocesses did not adequately capture the complex-
ity inherent in multifaceted functional measures.11 It is 
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possible that the paradigms adapted from social neurosci-
ence in the SCAF project will likewise show attenuated 
relationships with functionally meaningful outcomes. 
Attenuated relationships may provide evidence that func-
tional outcomes either depend on a more diffuse array 
of cognitive processes or do not centrally involve the 
components of the social-emotional processing stream 
targeted by SCAF paradigms. Alternatively, these adapted 
paradigms may improve the signal-to-noise ratio of social 
cognitive measurements if  they tap into cognitive pro-
cesses that are centrally involved in functional outcomes. 
Stronger relations to functional measures would arise in 
this scenario from an enhanced signal-to-noise ratio com-
pared with less pure, more multifaceted measures of social 
cognition.11
Like nonsocial cognition,12,13 social cognition has 
become a treatment target that is being actively inves-
tigated in schizophrenia research. The ultimate goal 
of clinical trials for these unmet treatment needs is to 
improve community integration for individuals with 
schizophrenia, such as return to work, improved fam-
ily and social relationships, and higher levels of inde-
pendent living. Community-based functional outcomes 
are, however, unlikely to change over the time frame of 
a typical clinical trial. Consequently, the US Food and 
Drug Administration has endorsed the inclusion of 
functionally meaningful coprimary measures in clinical 
trials of cognition-enhancing agents in schizophrenia.14 
Such coprimary measures include measures of functional 
capacity, which are simulation tasks that can be admin-
istered in the clinic, in which a participant demonstrates 
how they would perform a task.12,13 For clinical trial end-
points, it is therefore important to establish relationships 
between the proposed social cognition tasks and func-
tionally meaningful coprimary measures.
In the best-case scenario, these newly adapted measures 
would perform at least as well as existing measures of 
social cognition both in terms of correlations with exter-
nal variables and in terms of their capacity to explain 
variance beyond standard measures used in schizophre-
nia research. The present article is the third in a series 
describing the adaptation of measures with known neu-
ral correlates from cognitive and social neuroscience for 
use in schizophrenia clinical trials. Companion articles 
describe the theoretical background of the SCAF project 
and adapted social neuroscience measures,9 as well as the 
psychometric properties of those measures.15 The goal 
of this article is to characterize the relationship between 
the 4 social neuroscience measures and clinically and 
functionally meaningful variables. We present data on 
the correlations between these newly adapted measures 
and functional capacity, community functioning, as well 
as nonsocial cognition, and clinical symptoms. The sec-
ondary goal is to determine whether the new measures 
explain additional variance in functional capacity and 
community functioning above and beyond (1) nonsocial 




Participant characteristics, recruitment, inclusion/exclu-
sion criteria, and psychometric properties of the SCAF 
social neuroscience measures are described in a companion 
article.15 Briefly, participants for this study comprised 173 
individuals with schizophrenia drawn from 2 performance 
sites (University of California, Los Angeles and University 
of North Carolina [UNC] at Chapel Hill). Social neuro-
science paradigms were administered twice (baseline and 
4-week retest) with symptom severity assessed at both 
testing occasions. Administration of social neuroscience 
paradigms was counterbalanced across subjects to mini-
mize confounds. Together, the 4 paradigms take approxi-
mately an hour and a half to complete and are generally 
well tolerated. Although social neuroscience measures 
were administered twice to the patient group to evaluate 
test-test reliability, data from the first assessment time were 
used in the current analyses. Data from healthy controls 
are not presented here. After providing a complete descrip-
tion of the study to prospective study participants, written 
informed consent was obtained prior to participation.
Social Cognition
Social Neuroscience Paradigms. The 4 social neurosci-
ence paradigms and their theoretical background are 
fully described in a companion article.15 In brief, SCAF 
paradigms were selected by virtue of their neural sub-
strates relating to the constructs of either (1) bottom-up/
low-level perception of social/emotional stimuli or (2) 
top-down/high-level mental state inferences.10 Bottom-up 
(low-level) perception tasks comprised (1) basic biologi-
cal motion, capturing the ability to visually discriminate 
characteristic human motion from random motion repre-
sented by point-light figures16 and (2) emotion in biologi-
cal motion, capturing the ability to determine the emotion 
displayed by walking point-light figures17; top-down (high-
level) inferential processes comprised (3) self-referential 
memory, capturing memory biases in the encoding and 
retrieval of trait information about oneself vs others18,19 
and (4) empathic accuracy, capturing the ability to accu-
rately track the emotions of others over time.20,21
For the current article, we selected 1 representative 
variable from each of the social neuroscience paradigms 
for further analysis. For the basic biological motion test, 
the 70% and 85% coherent motion variables each had bet-
ter psychometric properties than 100% coherent motion. 
Given no sharp theoretical or psychometric rationale for 
preferring either 70% or 85%, we selected the 85% coher-
ent motion variable by virtue of its frequency distribution 
being slightly less skewed than that of the 70% coherent 
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motion variable. Accuracy measured as percent correct 
was used for the emotion in biological motion test. The 
self-referential memory test measures delayed recognition 
sensitivity to adjectives describing either the participant 
(self), generally desirable traits (other), or upper vs lower-
case text (physical). The “self” index of sensitivity variable 
was chosen to represent this construct based on its better 
discrimination of patients from controls.15 As explained 
elsewhere,15 participants received one of 2 versions of the 
empathic accuracy task: an older version developed at 
Columbia University by Zaki and colleagues20 or a new 
version developed at UCLA. Both versions contained 
positive and negative valence video clips of individuals 
discussing autobiographical events. Clips with extreme 
variability were subsequently dropped. Both tasks were 
designed to assess the same construct, and preliminary 
analyses revealed no differences across versions. Hence, 
9-clip versions of the Columbia and UCLA version of 
the empathic accuracy task were collapsed into a single 
measure for these analyses.
Facial Affect Identification. Because facial affect identifi-
cation tasks are commonly used in schizophrenia research 
and have established relationships to functioning,22,23 they 
provide a benchmark standard for evaluating the incremen-
tal validity of the SCAF paradigms. In this computerized 
version, participants were asked to identify facial expres-
sions of emotion in still photographs from a standardized 
stimulus set developed by Ekman.24 The test included digi-
tized color photos of 8 different posers displaying facial 
expressions of 6 basic emotions (happy, sad, angry, afraid, 
surprised, and disgusted) as well as a neutral expression for 
a total of 56 images. For each trial, a photo and a list of the 
7 possible expressions were simultaneously presented on 
the screen for 5 s. Participants stated their selected choice 
aloud. The dependent measure was percent accuracy.
Nonsocial Cognition
Nonsocial cognition was assessed using the Measurement 
and Treatment Research to Improve Cognition in 
Schizophrenia (MATRICS) Consensus Cognitive Battery 
(MCCB).25 Although the neurocognitive composite score 
from the MCCB normally includes one measure of social 
cognition, this test was excluded from our composite score, 
so that the neurocognitive composite score reflects only non-
social cognition and includes the domains of speed of pro-
cessing, verbal memory, visual memory, working memory, 
reasoning and problem solving, and attention/vigilance.
Symptoms
Presence and severity of psychiatric symptoms was 
assessed using the expanded Brief  Psychiatric Rating 
Scale (BPRS)26; scores for the Positive, Negative, and 
Depressive subscales are reported.27 Negative symp-
toms were assessed using the Scale for the Assessment of 
Negative Symptoms (SANS), which covers 5 domains: 
affective flattening, alogia, avolition-apathy, anhedonia-
asociality, and attention.28 A composite SANS score was 
computed as the sum of these domains with attention 
excluded. Training of symptom scale raters is described 
in the previous article on psychometric properties.15
Functional Measures
Functional Capacity. Functional capacity was assessed 
using 2 measures. The University of California at San 
Diego Performance-Based Skills Assessment (UPSA)29 is 
a role-play simulation task designed to measure partici-
pants’ ability to negotiate real-world tasks such as count-
ing correct change, understanding a utility bill, reading a 
bus schedule, and making a grocery list. The UPSA yield 
a summary score spanning measures of 5 functional skill 
areas: general organization, finance, social/communicati
ons, transportation, and household chores.
The Maryland Assessment of Social Competence 
(MASC)30 is a measure of social skills comprising 4 short 
role-play scenarios designed to measure participants’ abil-
ity to solve common interpersonal problems. Each con-
versation is 2 min long. Scripted confederate prompts and 
responses are minimal and open-ended, designed to enjoin 
participants to take primary responsibility for moving the 
conversation forward. The 4 scenarios consist of one involv-
ing initiating conversation with a new neighbor, 2 involving 
negotiation and compromise (eg, asking an employer for 
a second chance), and one involving standing up for one’s 
rights (ie, confronting a landlord about fixing a leaky roof). 
The procedure is videotaped for later scoring. Each scenario 
was coded by specially trained raters using three 5-point 
Likert scales: verbal skill (a measure of speech content), 
nonverbal skill (a measure of paralinguistic style, includ-
ing eye contact and body language), and overall effective-
ness (a composite measure of focus and goal achievement). 
The 2 domains sum to a total score. MASC raters received 
training from the developers of this task or individuals the 
developers had certified and achieved intraclass correlation 
coefficients exceeding 0.85 for all the MASC variables on a 
set of 10 videos that were derived from a separate sample.
Community Functioning. Community functioning was 
assessed via a total score summing the 4 subscales of 
the Role Functioning Scale (RFS)31: work functioning, 
independent living, family network, and social function-
ing. Ratings were based on a semistructured interview 
that used standardized probe questions. Higher UPSA, 
MASC, and RFS scores indicate better functioning.
Statistical Analysis
We first examined the interrelationships among the social 
neuroscience tasks with Pearson correlation coefficients. 
To examine the relationships between the social neuro-
science tasks and other variables, we computed Pearson 
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correlations between them and facial affect identification, 
symptoms, nonsocial cognition, functional capacity, and 
community functioning.
The external and incremental validity of  the social 
neuroscience tasks was examined via hierarchical linear 
regressions with UPSA, MASC, and RFS total scores 
as individual dependent variables. Preliminary analy-
sis were conducted to investigate possible differences 
across sites. The MCCB and functional outcome vari-
ables were used as independent measures in hierarchi-
cal regression analyses with the 4 social neuroscience 
variables entered in block 1 and a dummy variable (0,1) 
representing site along with an interaction term (social 
neuroscience variables x site) in block 2. An analogous 
set of  regression analyses was used to evaluate possible 
effects associated with the 2 versions of  the empathic 
accuracy task. These analyses showed no consistent 
site or version effects. Thus, site and version were not 
included as potential confounds in subsequent analyses.
Three sets of  regression analyses were performed 
with the 4 social neuroscience task variables entered 
in a single block in each analysis. In the first set of 
analyses, we assessed the variance in functional mea-
sures accounted for by social neuroscience tasks con-
sidered alone with the 4 representative variables in 
a single block. Second, we assessed additional vari-
ance explained beyond nonsocial cognition by enter-
ing MCCB composite scores in block 1 and the social 
neuroscience variables in block 2.  Third, we assessed 
additional variance explained beyond a standard mea-
sure of  facial affect recognition by entering facial affect 
identification scores in block 1 and the social neurosci-
ence variables in block 2. Because nonsocial cognition 
and facial affect recognition were expected to correlate 
well with the social neuroscience measures, we viewed 
this as a stringent test of  incremental validity.
Results
Correlational Analyses
Intercorrelations among the social neuroscience and 
facial affect identification tasks are shown in table 1. In 
general, these measures tended to be modestly and sig-
nificantly intercorrelated with correlations ranging from 
.17 to .53 and a mean correlation among the 4 social neu-
roscience tasks of .34.
Several of the social neuroscience tasks showed small but 
significant relationships with positive symptoms (table 2). 
Patients with greater positive symptoms performed worse 
on basic biological motion, self-referential memory, and 
empathic accuracy tasks. By contrast, there was only one 
significant association between the social neuroscience 
tasks and negative or depressive symptoms (SANS Total, 
BPRS Negative and Depressive subscales): more accurate 
perception of biological motion was associated with lower 
depressive symptoms.
The relationships among social neuroscience variables, 
facial affect identification, nonsocial cognition, and func-
tional outcome measures are shown in table 3. There 
were consistent positive relationships between the social 
neuroscience variables and the neurocognitive composite 
score, with correlations ranging from .27 to .45. Likewise, 
greater functional capacity as measured by the UPSA was 
associated with higher ability in each social neuroscience 
domain, with correlations ranging from .24 to .39. Thus, 
better perception of biological motion and emotion in 
Table 1. Intercorrelations Between Social Neuroscience Paradigms and Facial Affect Identification
1 2 3 4
1. Basic biological motion
2. Emotion in biological motion .39**
3. Self-referential memory .23** .34**
4. Empathic accuracy .17* .33** .23**
5. Facial affect identification .37** .53** .42** .37**
*P < .05, **P < .01.
Table 2. Correlations Between Social Neuroscience Paradigms and Facial Affect Identification With Symptom Measures
BPRS Positive BPRS Depression BPRS Negative SANS Total
Basic biological motion −.23** −.16* −.02 −.05
Emotion in biological motion −.10 .03 −.03 −.09
Self-referential memory −.21** −.14 −.02 −.10
Empathic accuracy −.23** .05 .01 −.11
Facial affect identification −.14 −.01 .01 −.13
Note: BPRS, Brief  Psychiatric Rating Scale; SANS, Scale for the Assessment of Negative Symptoms.
*P < .05, **P < .01.
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biological motion, better self-referential memory, and 
higher empathic accuracy were each associated with greater 
nonsocial cognitive ability and UPSA functional capacity.
Relationships between social neuroscience tasks and 
MASC social skills were mixed. Better perception of 
emotion in biological motion and higher empathic accu-
racy were associated with greater social skill. Perception 
of biological motion and self-referential memory were 
not significantly associated with MASC scores. The 
mean correlation with the MASC was .14. Relationships 
between social neuroscience tasks and community func-
tioning were also mixed. Higher empathic accuracy was 
associated with better community functioning as mea-
sured by the RFS, but the other 3 tasks were not asso-
ciated with community functioning. Overall, among the 
social neuroscience tasks, empathic accuracy showed the 
most consistent relations to MASC and RFS scores.
Multiple Regression Analyses
Social Neuroscience Measures Alone. Before examining 
incremental validity, the explanatory power of social neu-
roscience variables was assessed. As shown in table 4, the 
social neuroscience tasks significantly predicted 27% of the 
variance in functional capacity as measured by the UPSA 
(R2 = .27, F(4,153) = 13.9, P < .001) and 11% of the variance 
in MASC social skills (R2 = .11, F(4,150) = 4.43, P = .002) 
but did not significantly predict community functioning as 
measured by the RFS (R2 = .052, F(4,154) = 2.10, P = .084). 
Incremental Validity. Results from incremental validity 
multiple regression analyses are summarized in table 5. 
The social neuroscience tasks significantly predicted 
8% of the variance in MASC social skills beyond non-
social cognition (ΔR2  =  .076, ΔF(4,149)  =  3.38, P = 
.011). Greater functional capacity was associated in this 
model with worse self-referential memory (β  =  −.20, 
t(5,149) = −2.28, P = .024) and higher empathic accuracy 
(β  =  .20, t(5,149)  =  2.42, P = .017). The unexpected 
negative regression weight for self-referential memory 
reflected a subtle suppression effect; although self-refer-
ential memory was individually uncorrelated with MASC 
scores (see table 3), once all the other neurocognitive and 
social neuroscience variables were taken into account, the 
correlation became weakly negative. Social neuroscience 
variables did not significantly predict additional variance 
beyond nonsocial cognitive ability in functional capacity 
as measured by the UPSA or in community functioning.
Social neuroscience tasks significantly predicted 9% of 
the variance in functional capacity as measured by the 
UPSA (ΔR2 = .090, ΔF(4,152) = 4.85, P = .001) and 8% 
of MASC social skills (ΔR2  =  .075, ΔF(4,149)  =  3.13, 
 P = .017) beyond facial affect identification. Better self-
referential memory predicted greater UPSA functional 
capacity (β = .22, t(5,152) = 2.92, P = .004), and higher 
empathic accuracy predicted better MASC social skills 
(β =  .22, t(5,149) = 2.55, P = .012). None of the social 
cognitive tasks—including facial affect identification—
significantly predicted variance in community function-
ing in this analysis.
Discussion
The purpose of  this study was to examine the rela-
tionship between social cognitive paradigms adapted 
from social neuroscience and functionally meaning-
ful outcomes. Overall, the relationships were modest. 
Correlations between the adapted social neuroscience 
measures and functional capacity measured by the 
UPSA, while uniformly significant, were only slightly 
lower than previously observed correlations between 
the UPSA and social cognition measures.3 Correlations 
between the social neuroscience measures and both func-
tional capacity measured by the MASC and community 
functioning, however, generally fell below the range 
of  mean correlations reported by Fett and colleagues1 
Table 3. Correlations With External Variables
MCCB Composite UPSA Total MASC Total RFS Total
Mean (SD) 30.8 (12.3) .74 (0.13) 3.54 (0.48) 4.49 (1.13)
SCAF paradigms
 Basic biological motion .38** .24** .07 .10
 Emotion in biological motion .43** .39** .23** .13
 Self-referential memory .45** .39** .01 .12
 Empathic accuracy .27** .30** .27** .17*
Standard measures
 Facial affect identification .52** .45** .19* .23**
 MCCB composite n/a .69** .30** .28**
Note: MCCB, Measurement and Treatment Research to Improve Cognition in Schizophrenia  Consensus Cognitive Battery; UPSA, 
University of California at San Diego Performance-Based Skills Assessment; MASC, Maryland Assessment of Social Competence; RFS, 
Role Functioning Scale; SCAF, Social Cognition and Functioning; n/a, not applicable.
*P < .05, **P < .01.
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(.22–.48) in a meta-analysis of  the relationship between 
existing social cognitive and functional measures in 
schizophrenia. It is also notable that social neurosci-
ence measures showed generally weak correlations with 
symptoms, given that some studies have reported that 
social cognitive task performance correlates with nega-
tive symptoms.32
Regression analyses, which combined the 4 social neu-
roscience tasks into a single block of  predictors, provided 
modest evidence for external and incremental validity. 
The 4 social neuroscience paradigms were significant 
predictors of  functional capacity (UPSA and MASC) 
but not community functioning. Evidence for incremen-
tal validity over traditional predictors in schizophrenia 
(nonsocial cognitive ability and facial affect identifica-
tion) was also mixed. The social neuroscience paradigms 
demonstrated significant incremental validity beyond 
facial affect identification for functional capacity (UPSA 
and MASC; though the proportion of  explained vari-
ance was small) but not community functioning. The 
paradigms showed incremental validity beyond nonso-
cial cognition for MASC social skills but not for func-
tional capacity or community functioning. Note that 
we expected the 4 social neuroscience paradigms to cor-
relate with both nonsocial cognition and facial affect 
identification, which they did. Hence, the analyses are a 
stringent test of  incremental validity.
Overall, associations between the social neuroscience 
paradigms and external variables were disappointingly 
low, especially for community functioning. It is possible 
that relationships to external variables were impacted to 
some extent by differences across sites, a pattern that 
Table 5. Final Regression Models Predicting Additional Variance in Dependent Measures (UPSA, MASC, and RFS) Beyond (1) 
Nonsocial Cognition and (2) FAI
Block 1 Block 2
ΔR2
Predictor β Predictor β
MCCB FAI R2 MCCB FAI BBM EBM SRM EA R2
Nonsocial cognition
 UPSA .69** .47** .60** −.05 .09 .09 .10 .50** .03
 MASC .30** .09** .30** −.08 .14 −.20* .20* .17** .08*
 RFS .28** .08** .26** .04 .02 −.05 .11 .09** .02
FAI
 UPSA .45** .20** .21* .03 .16 .22** .11 .29** .09**
 MASC .18* .03* .05 −.01 .18 −.12 .22* .11** .08*
 RFS .21* .04** .12 .07 .03 −.002 .11 .06 .02
Note: Abbreviations are explained in the first footnote to table 3. FAI, facial affect identification; BBM, basic biological motion; SRM, 
self-referential memory; EA, empathic accuracy; EBM, emotion in biological motion.
*P < .05, **P < .01.
Table 4. Final Regression Models Predicting Overall Contribution of New Measures to Outcome
R2 Adjusted R2 F P β t P
UPSA total .27 .25 13.9 <.001
Basic biological motion .07 0.89 .374
Emotion in biological motion .23 2.87 .005
Self-referential memory .27 3.55 .001
Empathic accuracy .15 2.00 .049
MASC total .11 .08 4.43 .002
Basic biological motion −.004 −0.05 .964
Emotion in biological motion .20 2.19 .030
Self-referential memory −.11 −1.30 .197
Empathic accuracy .23 2.73 .007
RFS total .05 .03 2.10 .084
Basic biological motion .09 1.04 .298
Emotion in biological motion .07 0.80 .427
Self-referential memory .02 0.27 .786
Empathic accuracy .14 1.60 .112
Note: Abbreviations are explained in the first footnote to table 3.
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has been observed in other multisite psychometric stud-
ies.12,13 Although our regression analyses uncovered no 
systematic site effects, post hoc analyses showed higher 
relations between social neuroscience paradigms and 
functional capacity at UNC but higher relations to 
community functioning at UCLA. Notably, 2 of  4 para-
digms showed significant relationships to community 
functioning at the UCLA site but not at UNC. Thus, 
combining data across sites may obscure relationships 
that existed within site, possibly due to restricted range 
in outcome at a given site.
A few other factors should be considered when inter-
preting these findings. First, our measure of  commu-
nity functioning was based solely on patient self-reports 
without information from collateral informants, which 
could limit the validity of  these ratings.33 Second, cross-
sectional correlations might not be the best predictors 
of  functional improvement, so further investigation 
of  these measures should examine these relationships 
longitudinally.34 Third, the modest relationships to 
functionally meaningful outcomes may be due to the 
increased specificity of  neuroscience paradigms, which 
tap into 2 of  the 5 core constructs with identified neural 
substrates that comprise the social-emotional process-
ing stream.10 The attenuated relationships in this study 
are consistent with results from the application of  mea-
sures developed in the CNTRICS initiative, which also 
showed lower than hoped for associations to outcome 
measures.11 
It is perhaps not surprising to find more specific 
measures that tap into narrowly circumscribed neural 
regions of  interest to be more modestly related to com-
plex, multifaceted social tasks than more general mea-
sures capturing variance across multiple constructs.11 
Consequently, these results may be taken to show that 
the functional capacity measures and community func-
tioning measures in this study (UPSA, MASC, and 
RFS) encompass a broad spectrum of social-emotional 
processing capacities and do not depend heavily on the 
core neuroscience constructs that the SCAF paradigms 
captured. It is, however, somewhat difficult to reconcile 
this explanation with our finding that some of  the rela-
tionships between facial affect identification and func-
tionally meaningful outcomes in our regression analyses 
were also lower than that would be expected based on 
some previous studies examining emotion perception 
in schizophrenia, particularly for community function-
ing.1,22,35 Although it is intuitive that highly specific tasks 
would be less likely to capture variance in multidimen-
sional outcome measures,11 the facial affect identification 
task is itself  not particularly multifaceted; such expla-
nations must therefore reckon with relatively consistent 
relationships observed between emotion perception 
tasks and functionally meaningful outcomes.1,2 Further 
research should attempt to fathom why the magnitude of 
links between facial emotion perception and functioning 
fluctuate across studies, which could reflect factors such 
as the particular test used, patient characteristics, or 
social conditions (eg, family environment, economic and 
social benefit conditions).
In sum, although the adapted social neuroscience mea-
sures have firm grounding in neural systems, several of the 
tasks had modest external validity. These results under-
score the difficulty of translating insights from neurosci-
ence into tasks that are practical and appropriate for use 
in clinical trials. Of the adapted social neuroscience para-
digms, the basic biological motion paradigm performed 
most poorly in terms of both its relationships to external 
variables and its psychometric properties.15 The emotion in 
biological motion and self-referential memory paradigms 
each had somewhat stronger relationships to external vari-
ables and better psychometric properties than basic biolog-
ical motion. Given their strengths and weaknesses in terms 
of external validity and psychometrics,15 these paradigms 
may benefit from further development. The empathic 
accuracy paradigm appears to have the broadest external 
validity with significant association to all 3 functional out-
come measures. The empathic accuracy task also had the 
best psychometric properties of the 4 paradigms: empathic 
accuracy discriminated between patients and controls 
(Cohen’s d = 0.59) and had adequate test-retest reliability 
(r = .74).15 Thus, of the 4 tasks, the empathic accuracy task 
shows the greatest utility for clinical trials given its combi-
nation of known linkages to neural substrates, strong psy-
chometric properties, and external validity. It is the most 
highly recommended measure from the SCAF project.
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